688266 Suzhou Zelgen Biopharmaceuticals

Watchlist

Market Closed May 17 15:00 CST

14.91BMarket Cap-57177P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Stock Analyst Ratings & Price Target

Updated: May 17, 2024

Based on 13 analysts giving stock ratings to Suzhou Zelgen Biopharmaceuticals in the past 3 months

Strong Buy

Updated: May 17, 2024

The average Suzhou Zelgen Biopharmaceuticals stock price target is 65.11 with a max estimate of 74.52 and a min estimate of 58.00

Review Suzhou Zelgen Biopharmaceuticals earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Updated: May 17, 2024

Strong Buy

Updated: May 17, 2024

Overall